Oireachtas Joint and Select Committees

Thursday, 12 February 2015

Joint Oireachtas Committee on Health and Children

Quarterly Update on Health Issues: Discussion

9:30 am

Mr. Tony O'Brien:

Those things after pain management. We will provide her with the detailed answer. I will ask my colleague, Mr. John Hennessy, to come back to Deputy McLellan on her question on discretionary medical cards and on Daxas and Fampridine

I am sorry if we have not correctly identified the information that Deputy McLellan wanted. Sometimes we do not always fully get it. I will ask Mr. Ray Mitchell, who is here, to engage with the Deputy to ensure we have a proper understanding of what she requires and that she gets it.

We have discussed the issue of Hollybrook before. It is currently in use for a specific purpose. I understand, although I do not have the data, that many of the patients who are in it for its current purpose would be from the geographical area but it is not being used for its intended purpose. This is a transitional use linked to development of the national children's hospital.

In respect of the matter raised by Senator Crown, of which he was kind enough to give me advance notice, we will look into it.

It is clearly not intended for it to work in that way.

On the broader issue of obstetric services and emerging issues, we are in the process of putting in place a specific office in the National Hospitals Office to deal with this. It will be somewhat along the lines of the national organ donation and transplantation office and the national cancer control programme to bring a specific focus to how we manage the improvement in obstetric services. More will follow on that in the coming weeks.

I do not have access to the statement I made in writing on Soliris but it was made carefully. I will listen back to the comments I made this morning but I do not believe any reasonable person could construe it as a criticism of the patients in question. I have to be in a position to express a view about any drug company that seeks to charge more than what I consider reasonable for a particular drug. The reason we were commenting on it was because in this instance we were required to make a decision on it. In the other instances to which the Senator referred, we were not required to make a decision.